Home Cart 0 Sign in  
X

[ CAS No. 88139-91-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 88139-91-7
Chemical Structure| 88139-91-7
Chemical Structure| 88139-91-7
Structure of 88139-91-7 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 88139-91-7 ]

Related Doc. of [ 88139-91-7 ]

Alternatived Products of [ 88139-91-7 ]

Product Details of [ 88139-91-7 ]

CAS No. :88139-91-7 MDL No. :MFCD04035597
Formula : C6H6BrNO Boiling Point : -
Linear Structure Formula :- InChI Key :RUCZFWMEACWFER-UHFFFAOYSA-N
M.W : 188.02 Pubchem ID :5200169
Synonyms :
5-Bromo-2-pyridinemethanol
Chemical Name :5-Bromo-2-hydroxymethylpyridine

Calculated chemistry of [ 88139-91-7 ]

Physicochemical Properties

Num. heavy atoms : 9
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.17
Num. rotatable bonds : 1
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 38.06
TPSA : 33.12 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.96 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.51
Log Po/w (XLOGP3) : 0.69
Log Po/w (WLOGP) : 1.18
Log Po/w (MLOGP) : 0.65
Log Po/w (SILICOS-IT) : 1.89
Consensus Log Po/w : 1.18

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.87
Solubility : 2.55 mg/ml ; 0.0136 mol/l
Class : Very soluble
Log S (Ali) : -0.96
Solubility : 20.5 mg/ml ; 0.109 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.71
Solubility : 0.368 mg/ml ; 0.00196 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.52

Safety of [ 88139-91-7 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 88139-91-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 88139-91-7 ]
  • Downstream synthetic route of [ 88139-91-7 ]

[ 88139-91-7 ] Synthesis Path-Upstream   1~20

  • 1
  • [ 88139-91-7 ]
  • [ 31181-90-5 ]
Reference: [1] Tetrahedron, 1997, vol. 53, # 24, p. 8257 - 8268
  • 2
  • [ 31181-90-5 ]
  • [ 88139-91-7 ]
YieldReaction ConditionsOperation in experiment
86% With sodium tetrahydroborate In tetrahydrofuran; ethanol for 0.75 h; To a solution of   5-bromopyridine-2-carbaldehyde (5.00 g, 26.9 mmol) dissolved in a mixture of   ethanol (75 mL) and   THF (25 mL) was added   sodium borohydride (0.407 g, 10.8 mmol) in small portions. After 45 minutes 0.5 mL   water was added and the mixture and evaporated to dryness. The oily residue was subjected to flash chromatography (silica, EtOAc/EtOH/Et3N 90:5:5) to give   (5-bromo-pyridin-2-yl)-methanol (4.81 g, 86percent) as pale-yellow oil.
84%
Stage #1: With sodium tetrahydroborate In ethanol at 0 - 20℃; for 4 h;
Stage #2: With water; sodium hydrogencarbonate In ethanol
Example 14.1: (5-Bromo-pyridin-2-vl)-methanolA mixture of 5-bromo-pyridine-2-carbaldehyde (0.5 g, 2.68 mmol) in ethanol (30 ml_) was cooled in an ice bath. Sodium borohydride (0.41 g, 10.75 mmol) was added and the reaction mixture was stirred at room temperature for 4 hours. The reaction mixture was concentrated, dried, the residue dissolved in dichloromethane (30 ml.) and quenched with a saturated aqueous sodium bicarbonate solution. The organic phase was separated and the aqueous phase was extracted further with dichloromethane (2 x 10 ml_). The combined organic phase was dried over sodium sulfate and concentrated to give the product as an off- white solid (426 mg, 84 percent). 1H NMR (300 MHz, CDCI3): δ (ppm) 8.61 (d, 1 H), 7.82 (dd, 1 H), 7.23 (d, 1 H), 4.73 (s, 2H), 3.92 (bs, 1 H).
50% at 23℃; for 4 h; To a stirred solution of 5-bromopicolinaldehyde (0.5 g, 2.68 mmol, 1.0 eq) in methanol (10 mL) was added NaBH4 (0.18 g, 5.37 mmol, 2 eq) and stirred at room temperature for 4h. methanol was evaporated and diluted with with ethyl acetate (10mL), washed with water (15 mL), dried over sodium sulphate and evaporated under reduced pressure to get crude compound. This crude was purified by column chromatography using 100-200 silica gel 20 percent ethyl acetate-petrol ether as eluent system to get (5-bromopyridin-2- yl)methanol (0.2 g, 50 percent).
0.2 g With sodium tetrahydroborate In methanol at 20℃; for 4 h; Step 2
To a stirred solution of 5-bromopicolinaldehyde (0.5 g, 2.68 mmol, 1.0 eq) in methanol (10 mL) was added NaBH4 (0.18 g, 5.37 mmol, 2 eq) and stirred at room temperature for 4 h. methanol was evaporated and diluted with ethyl acetate (10 mL), washed with water (15 mL), dried over sodium sulfate and evaporated under reduced pressure to get crude compound.
This crude was purified by column chromatography using 100-200 silica gel 20percent ethyl acetate-petrol ether as eluent system to get (5-bromopyridin-2-yl)methanol (0.2 g, 50percent).
1.94 g at 0 - 20℃; for 2 h; In the 0 °C ice bath, add NaBH4 (1.220 g) to a solution of 5-bromopyridinecarboxaldehyde (2.010 g) in methanol (30 mL). After adding NaBH4, remove the water bath and naturally warm to room temperature. After stirring at room temperature for 2 hours, the reaction mixture was quenched with EtOAc. Extracted with EA (50 mL × 2), the combined organic phases were washed with a saturated NaCl solution. Drying over anhydrous Na2SO4 and concentrated to afford 1.940 g (5-bromopyridin-2-yl)methanol.

Reference: [1] Journal of Inorganic Biochemistry, 2012, vol. 111, p. 1 - 9
[2] Journal of Porphyrins and Phthalocyanines, 2010, vol. 14, # 6, p. 469 - 480
[3] Patent: US2013/12530, 2013, A1, . Location in patent: Paragraph 0178
[4] Patent: WO2008/32191, 2008, A2, . Location in patent: Page/Page column 58
[5] Patent: WO2013/13815, 2013, A1, . Location in patent: Page/Page column 228
[6] Chemistry - A European Journal, 2006, vol. 12, # 13, p. 3472 - 3483
[7] Bioorganic and Medicinal Chemistry Letters, 2008, vol. 18, # 4, p. 1407 - 1412
[8] Patent: WO2004/814, 2003, A1, . Location in patent: Page 70
[9] Journal of the American Chemical Society, 2009, vol. 131, # 40, p. 14508 - 14520
[10] Patent: WO2006/60461, 2006, A1, . Location in patent: Page/Page column 165
[11] Patent: US2007/105904, 2007, A1, . Location in patent: Page/Page column 100
[12] Patent: US2013/29962, 2013, A1, . Location in patent: Paragraph 1102
[13] Angewandte Chemie - International Edition, 2013, vol. 52, # 25, p. 6464 - 6467[14] Angew. Chem., 2013, vol. 125, # 25, p. 6592 - 6595,4
[15] Journal of the American Chemical Society, 2013, vol. 135, # 38, p. 14052 - 14055
[16] Patent: WO2016/82930, 2016, A1, . Location in patent: Page/Page column 37-38
[17] Patent: EP1873153, 2008, A1, . Location in patent: Page/Page column 89
[18] Patent: TW2018/29406, 2018, A, . Location in patent: Page/Page column 29
  • 3
  • [ 31181-64-3 ]
  • [ 88139-91-7 ]
YieldReaction ConditionsOperation in experiment
77%
Stage #1: at 20 - 53℃; for 1 h;
Stage #2: With sodium hydrogencarbonate In water at 20℃;
To a flask containing 5-Bromo-2-methyl-pyridine 1-oxide (1.14g, 6.20mmol) purged with argon was slowly added trifluoroacetic acid (lOmL). The mixture stirred for 0.5hrs at room temperature and 0.5hrs at 53°C. The mixture was cooled and diluted with saturated sodium bicarbonate. The aqueous solution stirred overnight at room temperature and was extracted with ethyl acetate, and concentrated to afford the title compound (895mg, 77percent) as a brown solid. *H NMR (300 MHz, CDCI3): 8 8.64 (s, 1H), 7.83 (d, 1H), 7.22 (d, 1H), 4.75 (s, 2H).
Reference: [1] Patent: WO2006/20879, 2006, A1, . Location in patent: Page/Page column 114
[2] Journal of Medicinal Chemistry, 1987, vol. 30, # 5, p. 871 - 880
[3] Tetrahedron, 1997, vol. 53, # 24, p. 8257 - 8268
[4] Journal of Medicinal Chemistry, 2011, vol. 54, # 13, p. 4721 - 4734
  • 4
  • [ 30766-11-1 ]
  • [ 88139-91-7 ]
YieldReaction ConditionsOperation in experiment
64%
Stage #1: With dimethylsulfide borane complex In tetrahydrofuran at 0 - 20℃; for 24 h;
Stage #2: With methanol In tetrahydrofuran at 0℃; for 1 h; Reflux
A-3: 6-Methoxymethyl-3-(pyrimidin-5-ylamino)-pyridine-2-carboxylic acid methyl esterStep 1: 5-Bromo-pyridin-2-yl-methanolTo a solution of 5-bromopyridin-2-carboxylic acid (8 g, 42.1 mmol) in THF (100 ml) was added borane-dimethylsulphide (16 ml, 168.30 mmol) dropwise at 0° C. After warming-up to ambient temperature stirring was continued for 24 hours. The solution was cooled again to 0° C., quenched with MeOH and refluxed for 1 h. Solvents were removed and the residue was treated with water. The aqueous phase was extracted with ethyl acetate and the combined organic layers were washed with water and brine, dried, filtered and concentrated under reduced pressure to afford 4.76 g (64percent) of the title compound.MS: M=188.0 190.0 (M+H)+
64%
Stage #1: With dimethylsulfide borane complex In tetrahydrofuran at 0 - 20℃; for 24 h;
Stage #2: With methanol In tetrahydrofuran for 1 h; Reflux
A-3: 6-Methoxymethyl-3-fpyrimidin-5-ylamino)-pyridine-2-carboxylic acid methyl esterStep 1: 5-Bromo-pyridin-2-yl-methanolTo a solution of 5-bromopyridin-2-carboxylic acid (8 g, 42.1 mmol) in THF (100 ml) was added borane-dimethylsulphide (16 ml, 168.30 mmol) dropwise at 0°C. After warming-up to ambient temperature stirring was continued for 24 hours. The solution was cooled again to 0°C, quenched with MeOH and refluxed for lh. Solvents were removed and the residue was treated with water. The aqueous phase was extracted with ethyl acetate and the combined organic layers were washed with water and brine, dried, filtered and concentrated under reduced pressure to afford 4.76 g (64 percent) of the title compound.+MS: M = 188.0 190.0 (M+H)
64%
Stage #1: With dimethylsulfide borane complex In tetrahydrofuran at 0 - 20℃; for 24 h;
Stage #2: With methanol In tetrahydrofuran at 0℃; for 1 h; Reflux
To a solution of 5-bromopyridin-2-carboxylic acid (8 g, 42.1 mmol) in THF (100 ml) was added borane-dimethylsulphide (16 ml, 168.30 mmol) dropwise at 0° C. After warming-up to ambient temperature stirring was continued for 24 hours. The solution was cooled again to 0° C., quenched with MeOH and refluxed for 1 h. Solvents were removed and the residue was treated with water. The aqueous phase was extracted with ethyl acetate and the combined organic layers were washed with water and brine, dried, filtered and concentrated under reduced pressure to afford 4.76 g (64percent) of the title compound. MS: M=188.0 190.0 (M+H)+
64%
Stage #1: With dimethylsulfide borane complex In tetrahydrofuran at 0 - 20℃; for 24 h; Inert atmosphere
Stage #2: With methanol In tetrahydrofuran at 0℃; Reflux
To a solution of 5-bromopyridin-2-carboxylic acid (8 g, 42.1 mmol) in THF (100 ml) was added borane-dimethylsulphide (16 ml, 168.30 mmol) dropwise at 0°C. After warming-up to ambient temperature stirring was continued for 24 hours. The solution was cooled again to 0°C, quenched with MeOH and refluxed for lh. Solvents were removed and the residue was treated with water. The aqueous phase was extracted with ethyl acetate and the combined organic layers were washed with water and brine, dried, filtered and concentrated under reduced pressure to afford 4.76 g (64 percent) of the title compound. MS: M = 188.0 190.0 (M+H)+

Reference: [1] Patent: US2011/183979, 2011, A1, . Location in patent: Page/Page column 17-18
[2] Patent: WO2011/89132, 2011, A1, . Location in patent: Page/Page column 44
[3] Patent: US2011/306589, 2011, A1, . Location in patent: Page/Page column 38
[4] Patent: WO2011/154327, 2011, A1, . Location in patent: Page/Page column 101
[5] Patent: CN103360407, 2016, B,
  • 5
  • [ 29682-15-3 ]
  • [ 88139-91-7 ]
YieldReaction ConditionsOperation in experiment
94.8% With sodium tetrahydroborate In methanol at 20℃; for 12 h; Cooling with ice 5-bromo-2-pyridinecarboxylic acid, methyl ester (648mg, 3mmol) was dissolved in a solution of methanol (10ml) was slowly added sodium borohydride (340mg, 9mmol) in an ice bath after complete addition the ice bath was removed, warmed to at room temperature, the reaction was stirred for 12 hours; then 1N HCl was added to adjust PH 1, again was added saturated sodium bicarbonate solution to adjust PH 8, and then extracted with ethyl acetate, the organic phase was dried over anhydrous magnesium sulfate and filtered , concentrated under reduced pressure to give 5-bromo-2-pyridinemethanol (535 mg of the, white solid), yield: 94.8percent.
90%
Stage #1: at 0 - 20℃;
Stage #2: With hydrogenchloride In water
Stage #3: With potassium carbonate In water
Intermediate 5,4 (5 -Bromopyridin-2-y] (methanol Methyl 5-bromopyridine-2-carboxylate (2.00 g, 9.27 mmol) was dissolved in ethanol (20.0 mL). Sodium borohydride (1 .05 g, 27.8 mmol) was added at 0°C, and the mixture was stirred at room temperature for 18 h. The mixture was then concentrated under reduced pressure, quenched with 1 N hydrochloric acid, neutralized with solid potassium carbonate and extracted with dichloro- methane. The organic layer was dried over magnesium sulfate and evaporated to give 1.57 g (90percent of th.) of the title compound. LC-MS (method 6): Rt = 0.56 min; MS (ESIpos): m/z (percent) = 188.0 (100) [M+H]+.
Reference: [1] Patent: CN103360407, 2016, B, . Location in patent: Paragraph 0135; 0138; 0139
[2] Patent: WO2013/4551, 2013, A1, . Location in patent: Page/Page column 35
[3] Chemistry - A European Journal, 2011, vol. 17, # 38, p. 10670 - 10681
  • 6
  • [ 624-28-2 ]
  • [ 68-12-2 ]
  • [ 88139-91-7 ]
YieldReaction ConditionsOperation in experiment
59.2%
Stage #1: With n-butyllithium In hexane; toluene at -78℃; for 2 h;
Stage #2: at -78℃; for 0.166667 h;
Manufacturing Example 54-1-1 (5-Bromo-pyridin-2-yl)-methanol; To a toluene (300 mL) solution of 2,5-dibromopyridine (10.0 g, 42.2 mmol) was added dropwise n-butyl lithium (2.55 M n-hexane solution, 18.2 mL, 46.4 mmol) on a dry ice-ethanol bath (-78° C.) under nitrogen atmosphere, which was stirred for 2 hours at -78° C. N,N-dimethylformamide (3.7 g, 50.6 mmol) was then added dropwise thereto and stirred for 10 minutes at -78° C. Sodium borohydride (3.20 g, 84.4 mmol) and methanol (20.0 mL) were then added and stirred for 30 minutes at room temperature. Water was added to the reaction solution, which was then extracted with ethyl acetate. The organic layer was washed with saturated aqueous sodium chloride, and the solvent was evaporated under a reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate:heptane=1:1-->2:1) to obtain the title compound (4.70 g, 59.2percent).1H-NMR Spectrum (DMSO-d6) δ (ppm): 4.54 (2H, d, J=5.6 Hz), 5.28 (1H, t, J=5.6 Hz), 7.44-7.47 (1H, m), 8.03-8.05 (1H, m), 8.59-8.60 (1H, m).
Reference: [1] Tetrahedron Letters, 2000, vol. 41, # 22, p. 4335 - 4338
[2] Patent: US2009/82403, 2009, A1, . Location in patent: Page/Page column 101
[3] Journal of Medicinal Chemistry, 2007, vol. 50, # 21, p. 5147 - 5160
[4] Patent: EP2301930, 2016, B1, . Location in patent: Paragraph 0063
  • 7
  • [ 900186-89-2 ]
  • [ 88139-91-7 ]
YieldReaction ConditionsOperation in experiment
80% With potassium carbonate In tert-butyl methyl ether; water at 20℃; for 1 h; Step II; A slurry of compound 36 (10.0 g, 33.1 mmol) in TBME (100 ml) was treated with 20percent potassium carbonate (20 ml) solution and stirred at room temperature for 1 h. The layers were separated and the organic layer was washed with water. The solution thus obtained was concentrated to 10 mL volume and 20 mL heptanes was added at 45-50 C. Solution was cooled to 20-25 C and additional 20 mL heptanes was charged. Reaction was agitated at 20-25 C for 2 hours and filtered. Product was dried overnight under vacuum at 15-25 C to give 5.0 g (80percent) of product. 1H NMR (CDCl3) δ 3.36 (bs, Hz, 1 -OH), 4.75 (d, J=9.07 Hz, 2H), 7.21 (d, J=8.31 Hz, 1H), 7.83 (d, J=8.28 Hz, 1H), 8.64 (d, J=1.89 Hz, 1H).
Reference: [1] Patent: US2008/4449, 2008, A1, . Location in patent: Page/Page column 14
[2] Patent: WO2006/76415, 2006, A2, . Location in patent: Page/Page column 46
  • 8
  • [ 3430-13-5 ]
  • [ 88139-91-7 ]
YieldReaction ConditionsOperation in experiment
78%
Stage #1: With 3-chloro-benzenecarboperoxoic acid In dichloromethane for 2 h;
Part A: Compound 413 (3.5 g, 20.7 mmol) was dissolved in methylene chloride (100 ml) and m-CPBA (4.95 g, 28.9 mmol) was added. The reaction mixture was stirred for two hours and then quenched with saturated sodium carbonate and stirred overnight. The organic layer was dried over sodium sulfate and the concentrated to provide a yellow solid (3.8 g). The solid was placed under argon and trifluoroacetic anhydride (15 mL) was added slowly. The reaction was stirred for 30 minutes at room temperature and then refluxed for 30 minutes. The reaction was cooled to room temperature and quenched slowly with saturated sodium bicarbonate. Methylene chloride was added and the organic layer was washed dried over sodium sulfate and concentrated. Column chromatography (2 to 1 ethyl acetate/hexanes) provided the desired product (3.O g, 78percent).1H NMR (400 MHz, CDCI3) δ 8.65 (d, 1H), 7.8 (m, 1H), 7.2 (d, 1H), 4.7 (s, 2H).
Reference: [1] Patent: WO2007/84451, 2007, A1, . Location in patent: Page/Page column 146
[2] Journal of Medicinal Chemistry, 1987, vol. 30, # 5, p. 871 - 880
[3] Polyhedron, 2010, vol. 29, # 7, p. 1854 - 1862
[4] Journal of Medicinal Chemistry, 2011, vol. 54, # 13, p. 4721 - 4734
  • 9
  • [ 77199-09-8 ]
  • [ 88139-91-7 ]
YieldReaction ConditionsOperation in experiment
80%
Stage #1: With sodium tetrahydroborate In methanol at 20 - 70℃; for 0.833333 h;
Stage #2: With hydrogenchloride In water
Example 593-(((5-(l-(4-(2,3-Dimethylphenoxy)butanoyl)-l,2,3,4-tetrahydroquinolin-5-yl)pyridin-2- yl)methoxy)carbonylamino)propanoic acid[00204] To a solution of NaBH4 (0.822 g, 21.73 mmol) in MeOH (25 mL) was added ethyl 5-bromopicolinate (1.0 g, 4.35 mmol) portion-wise over a period of 10 min at room temperature. The mixture was stirred at room temperature for 10 min and then heated to 70 °C for 30 min. The solvent was removed in vacuo, and the resulting residue was diluted with EtOAc and water. The aqueous phase was adjusted to pH 7 with 1 N aq. HCl, and extracted with EtOAc. The combined organic layer was dried over MgS04, filtered, and concentrated in vacuo to afford the title compound (0.65 g, 80percent yield) as a white solid. LCMS, [M+H]+ = 187.9.
Reference: [1] Patent: WO2012/149236, 2012, A1, . Location in patent: Page/Page column 162
  • 10
  • [ 110-91-8 ]
  • [ 31181-90-5 ]
  • [ 294851-95-9 ]
  • [ 88139-91-7 ]
YieldReaction ConditionsOperation in experiment
69%
Stage #1: With acetic acid In dichloromethane for 0.5 h;
Stage #2: With sodium tris(acetoxy)borohydride In dichloromethane at 20℃; for 4 h;
To a solution of 5-bromo-pyridine-2-carbaldehyde (0.30 g, 1.62 mmol) in DCM (15 ml.) was added morpholine (0.1O g, 1.13 mmol) and glacial acetic acid (2 mL) and stirred the resulting reaction mixture for 30 min. followed by addition of sodium triacetoxyborohydride (0.86 g, 4.05 mmol). The resulting reaction mixture was stirred for 4 h at room temperature. After completion of reaction (TLC monitoring), the reaction mixture was diluted with DCM, added water and extracted the organic layer. The organic layer was dried over Na2SO4 and concentrated. The crude residue was purified over silica- gel [100-200 M, compound H-A (0.21 g, 69percent) eluted in 1.50percent EtOAc-hexane and compound H-B (0.12 g, 28percent) eluted in 5 percent EtOAc-hexane.
Reference: [1] Patent: WO2009/74812, 2009, A1, . Location in patent: Page/Page column 77
  • 11
  • [ 31181-74-5 ]
  • [ 88139-91-7 ]
Reference: [1] Tetrahedron, 1997, vol. 53, # 24, p. 8257 - 8268
[2] Patent: WO2007/120729, 2007, A2, . Location in patent: Page/Page column 35
  • 12
  • [ 900186-88-1 ]
  • [ 88139-91-7 ]
Reference: [1] Journal of Organic Chemistry, 2004, vol. 69, # 2, p. 250 - 262
  • 13
  • [ 109-06-8 ]
  • [ 88139-91-7 ]
Reference: [1] Journal of Medicinal Chemistry, 1987, vol. 30, # 5, p. 871 - 880
[2] Polyhedron, 2010, vol. 29, # 7, p. 1854 - 1862
  • 14
  • [ 624-28-2 ]
  • [ 88139-91-7 ]
Reference: [1] Chemistry - A European Journal, 2006, vol. 12, # 13, p. 3472 - 3483
[2] Angewandte Chemie - International Edition, 2013, vol. 52, # 25, p. 6464 - 6467[3] Angew. Chem., 2013, vol. 125, # 25, p. 6592 - 6595,4
[4] Journal of the American Chemical Society, 2013, vol. 135, # 38, p. 14052 - 14055
  • 15
  • [ 97483-77-7 ]
  • [ 88139-91-7 ]
Reference: [1] Patent: WO2013/13815, 2013, A1,
[2] Patent: US2013/29962, 2013, A1,
[3] Patent: WO2016/82930, 2016, A1,
  • 16
  • [ 88139-91-7 ]
  • [ 143-33-9 ]
  • [ 31795-61-6 ]
YieldReaction ConditionsOperation in experiment
48% With copper(l) iodide In propiononitrile at 110℃; for 4 h; Step 2:; (5-Bromo-pyridin-2-yl)-methanol (1.0 g), NaCN (521 mg), Pd(PPh3)4 (612 mg), and CuI (200 mg) were taken up in degassed EtCN and heated at 110°C (4 h). The solution was partitioned between EtOAc and 10 percent NH4OH (aq.). The aqueous layer was extracted with EtOAc. The combined organic layers were washed with brine and dried (MgSO4). Filtration and concentration gave a yellow solid. Purification via flash chromatography (1/2 hexanes/EtOAc, Siψ2) gave 341 mg (48 percent) of (5-cyano-pyridin-2-yl)-methanol as a white solid.
Reference: [1] Patent: WO2006/60461, 2006, A1, . Location in patent: Page/Page column 165-166
  • 17
  • [ 557-21-1 ]
  • [ 88139-91-7 ]
  • [ 31795-61-6 ]
YieldReaction ConditionsOperation in experiment
1.38 g With dicyclohexyl-(2',6'-dimethoxybiphenyl-2-yl)-phosphane; tris-(dibenzylideneacetone)dipalladium(0) In N,N-dimethyl-formamide at 80℃; for 7.5 h; Inert atmosphere Preparation of 6-(hydroxymethyl)nicotinonitrile (17A). A mixture of 5-bromo-2-hydroxymethylpyridine (4.90 g, 26.1 mmol), S-phos dicyclohexyl(2',6'-dimethoxy-[l,r-biphenyl]-2-yl)phosphine (250 mg, 0.609 mmol), zinc cyanide (1.90 g, 16.2 mmol), and tris(dibenzylideneacetone) dipalladium (250 mg, 0.273 mmol) in DMF (5.5 mL) was degassed with a stream of Ar passing through the mixture for 1 minute. The mixture was heated at 80 °C under N2. After 4.5 hours, a second batch of the catalysts were prepared by mixing S-phos dicyclohexyl(2',6'-dimethoxy-[l, l'-biphenyl]-2- yl)phosphine (250 mg, 0.609 mmol) and tris (dibenzylideneacetone) dipalladium (250 mg, 0.273 mmol) in DMF (2 mL) under N2. The mixture was stirred at 35 °C for 2 minutes before it was added to the reaction mixture. After an additional 3 hours, water (0.5 mL) was added. The mixture was stirred for 1.5 hours and was allowed to cool to room temperature and was mixed with silica gel. The solvents were removed at 50 °C. The solids were purified by chromatography on silica using EtOAc in heptane (20-50percent) as eluent to give 6- (hydroxymethyl)nicotinonitrile (17A) as a white powder (1.38 g). MS m/z = 135 [M+H]+. 'HNMR (400 MHz, CDC13) δ 8.85 (s, IH), 7.97 (dd, J=1.96, 8.02 Hz, IH), 7.47 (d, J=8.22 Hz, IH), 4.86 (s, 2H), 2.61-3.26 (m, IH).
Reference: [1] Patent: WO2017/24180, 2017, A1, . Location in patent: Page/Page column 142-143
  • 18
  • [ 88139-91-7 ]
  • [ 168823-76-5 ]
YieldReaction ConditionsOperation in experiment
92% With thionyl chloride In dichloromethane at 0 - 20℃; for 3 h; Part B: Compound 413A (500 mg, 2.7 mmol) was dissolved in methylene chloride (5 mL) and cooled in an ice bath. Thionyl chloride (480 mg, 4.05 mmol) was added dropwise and stirred at room temperature for 3 hours. The reaction was quenched with saturated sodium bicarbonate. The organic layer was dried over sodium sulfate and concentrated to provide the desired product (510 mg, 92percent).
0.8 g With thionyl chloride In dichloromethane at 0℃; for 4 h; Step 1
Preparation of 5-Bromo-2-chloromethyl-pyridine
To a stirred solution of (5-Bromo-pyridin-2-yl)-methanol (1 g, 5.319 mmol) in CH2Cl2 (20 mL) is added drop wise thionyl chloride (0.57 mL, 7.979 mmol) at 0° C. then stirred for another 4 hours.
Reaction mixture is diluted with saturated sodium bicarbonate solution and extracted with CH2Cl2.
Organic layer is dried over sodium sulphate, solvent is evaporated in vacuo and purified by column chromatography using 7percent ethyl acetate in hexane as an eluent to afford the title compound (0.8 g).
1HNMR (400 MHz, DMSO-d6) δ: 4.7 (s, 2H), 7.53 (d, 8.36 Hz, 1H), 8.09-8.11 (dd, J1=2.44 Hz, J2=8.23 Hz, 1H), 8.69 (d, J=2.4 Hz, 1H), LC-MS (m/z): [M+H]=206.0.
4 g With thionyl chloride In dichloromethane at 0 - 20℃; for 4 h; To the stirred solution of (5-Bromo-pyridin-2-yl)-Methanol (5gm, 26.59mmol, 1 eq) in DCM (50mL) at 0°C is added Thionyl chloride (3ml_) drop wise at RT then stirred at RT for 4h. After completion, the reaction mixture quenched with saturated sodium bicarbonate solution and extracted with DCM (3X100ml_). The combined organic layer dried over sodium sulphate and evaporated under reduced pressure. The crude is purified by column chromatography using silica 100-200 mesh using 10percent EtOAc: Hexane as eluent to afford title compound (4g) as brown colored liquid. 1 NMR (400 MHz, DMSO) δ: 4.77 (s, 2H), 7.54 (d, J = 8.64Hz, 1 H), 8.09-8.12 (dd, J1 = 2.4Hz, J2 = 8.32Hz, 1 H), 8.70 (d, J = 5.96Hz, 1 H).
Reference: [1] Journal of Porphyrins and Phthalocyanines, 2010, vol. 14, # 6, p. 469 - 480
[2] Patent: WO2007/84451, 2007, A1, . Location in patent: Page/Page column 147
[3] Chemistry - A European Journal, 2011, vol. 17, # 38, p. 10670 - 10681
[4] Journal of Organic Chemistry, 2004, vol. 69, # 2, p. 250 - 262
[5] Patent: WO2006/76415, 2006, A2, . Location in patent: Page/Page column 46
[6] Patent: US2008/4449, 2008, A1, . Location in patent: Page/Page column 13-14
[7] Patent: WO2011/14774, 2011, A1, . Location in patent: Page/Page column 29
[8] Journal of Medicinal Chemistry, 2011, vol. 54, # 13, p. 4721 - 4734
[9] Patent: US2013/237502, 2013, A1, . Location in patent: Paragraph 0323
[10] Patent: WO2014/172443, 2014, A1, . Location in patent: Page/Page column 21
  • 19
  • [ 88139-91-7 ]
  • [ 380894-77-9 ]
Reference: [1] Patent: CN105330689, 2016, A,
  • 20
  • [ 88139-91-7 ]
  • [ 936342-91-5 ]
YieldReaction ConditionsOperation in experiment
98% at 20℃; for 12 h; 5-bromo-2-pyridinemethanol (500 mg, 2.66 mmol) was dissolved in thionyl chloride (5 ml) at room temperature, The mixture was stirred for 12 hours and concentrated under reduced pressure to 5-bromo-2-chloromethylpyridine monohydrochloride(635 mg, white solid) in 98percent yield.
69.2% With thionyl chloride In toluene at 0 - 20℃; for 0.0833333 h; Manufacturing Example 54-1-2 5-Bromo-2-chloromethyl-pyridine hydrochloride; To a toluene (20.0 mL) solution of (5-bromo-pyridin-2-yl)-methanol (4.70 g, 25.0 mmol) described in Manufacturing Example 54-1-1 was added dropwise thionyl chloride (3.65 mL, 50.1 mmol) on an ice bath (0° C.) under nitrogen atmosphere, which was stirred for 5 minutes at room temperature. The solvent was evaporated under a reduced pressure to obtain the title compound (4.2 g, 69.2percent) as a hydrochloride.1H-NMR Spectrum (DMSO-d6) δ (ppm): 4.78 (2H, s), 7.55-7.57 (1H, m), 8.11-8.14 (1H, m), 8.70-8.72 (1H, m).
69.2% With thionyl chloride In toluene at 0 - 20℃; for 0.0833333 h; To a toluene (20.0 mL) solution of (5-bromo-pyridin-2-yl)-methanol (4.70 g, 25.0 mmol) described in Manufacturing Example 54-1-1 was added dropwise thionyl chloride (3.65 mL, 50.1 mmol) on an ice bath (0° C.) under nitrogen atmosphere, which was stirred for 5 minutes at room temperature. The solvent was evaporated under a reduced pressure to obtain the title compound (4.2 g, 69.2percent) as a hydrochloride. 1H-NMR Spectrum (DMSO-d6) δ (ppm): 4.78 (2H, s), 7.55-7.57 (1H, m), 8.11-8.14 (1H, m), 8.70-8.72 (1H, m).
Reference: [1] Patent: CN103360407, 2016, B, . Location in patent: Paragraph 0135; 0140; 0141
[2] Patent: US2009/82403, 2009, A1, . Location in patent: Page/Page column 101
[3] Patent: US2007/105904, 2007, A1, . Location in patent: Page/Page column 101
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 88139-91-7 ]

Bromides

Chemical Structure| 374633-33-7

[ 374633-33-7 ]

3-Bromo-2-hydroxy-6-picoline

Similarity: 0.79

Chemical Structure| 74115-13-2

[ 74115-13-2 ]

5-Bromo-3-pyridinol

Similarity: 0.74

Chemical Structure| 33674-96-3

[ 33674-96-3 ]

(6-Bromopyridin-2-yl)methanol

Similarity: 0.73

Chemical Structure| 97483-77-7

[ 97483-77-7 ]

5-Bromopicolinonitrile

Similarity: 0.73

Chemical Structure| 3430-31-7

[ 3430-31-7 ]

3-Bromo-2,6-dimethylpyridine

Similarity: 0.71

Alcohols

Chemical Structure| 374633-33-7

[ 374633-33-7 ]

3-Bromo-2-hydroxy-6-picoline

Similarity: 0.79

Chemical Structure| 74115-13-2

[ 74115-13-2 ]

5-Bromo-3-pyridinol

Similarity: 0.74

Chemical Structure| 33674-96-3

[ 33674-96-3 ]

(6-Bromopyridin-2-yl)methanol

Similarity: 0.73

Chemical Structure| 146679-66-5

[ 146679-66-5 ]

3-Bromo-4-pyridinemethanol

Similarity: 0.71

Chemical Structure| 865156-59-8

[ 865156-59-8 ]

4-Bromo-6-methylpyridin-2-ol

Similarity: 0.69

Related Parent Nucleus of
[ 88139-91-7 ]

Pyridines

Chemical Structure| 374633-33-7

[ 374633-33-7 ]

3-Bromo-2-hydroxy-6-picoline

Similarity: 0.79

Chemical Structure| 74115-13-2

[ 74115-13-2 ]

5-Bromo-3-pyridinol

Similarity: 0.74

Chemical Structure| 33674-96-3

[ 33674-96-3 ]

(6-Bromopyridin-2-yl)methanol

Similarity: 0.73

Chemical Structure| 97483-77-7

[ 97483-77-7 ]

5-Bromopicolinonitrile

Similarity: 0.73

Chemical Structure| 3430-31-7

[ 3430-31-7 ]

3-Bromo-2,6-dimethylpyridine

Similarity: 0.71